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Abstract
The objective of this study was to screen a dog population from Belgium, the Netherlands and Germany for the presence of
mutant alleles associated with hip dysplasia (HD), degenerative myelopathy (DM), exercise-induced collapse (EIC), neuronal
ceroid lipofuscinosis 4A (NCL), centronuclear myopathy (HMLR), mucopolysaccharidosis VII (MPS VII), myotonia congenita
(MG), gangliosidosis (GM1) and muscular dystrophy (Duchenne type) (GRMD). Blood samples (K3EDTA) were collected for
genotyping with Kompetitive Allele Specific PCR (n = 476). Allele and genotype frequencies were calculated in those breeds
with at least 12 samples (n = 8). Hardy-Weinberg equilibrium was tested. Genetic variation was identified for 4 out of 9
disorders: mutant alleles were found in 49, 15, 3 and 2 breeds for HD, DM, EIC and NCL respectively. Additionally, mutant
alleles were identified in crossbreeds for both HD and EIC. For HD, DM, EIC and NCL mutant alleles were newly discovered in
43, 13, 2 and 1 breed(s), respectively. In 9, 2 and 1 breed(s) for DM, EIC and NCL respectively, the mutant allele was detected,
but the respective disorder has not been reported in those breeds. For 5 disorders (HMLR, MPS VII, MG, GM1, GRMD), the
mutant allele could not be identified in our population. For the other 4 disorders (HD, DM, EIC, NCL), prevalence of
associated mutant alleles seems strongly breed dependent. Surprisingly, mutant alleles were found in many breeds where
the disorder has not been reported to date.
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Introduction
The reduction of genetic disorders remains an important goal
for both veterinarians and breeders [1]. It is the responsibility of
the scientific community to provide detailed information regarding
the existence, application and importance of diagnostic genetic
tests that have been developed [1–3]. An important step in this
process is to evaluate the prevalence of disorders and mutant
alleles in the population. This information is needed to provide
proper breeding advice. So far, only a few studies have been
conducted to identify allele frequencies in a canine population [3–
6]. The presence of mutant alleles in different breeds with each
having their specific genetic background, might provide interesting
(clinical) information for both the animal and human population
as many canine disorders are animal models for human genetic
disorders.
This study reports on the prevalence of mutant alleles associated
with 9 canine genetic disorders (Table 1) that influence the
neuronal and/or musculoskeletal system: hip dysplasia (HD),
degenerative myelopathy (DM), exercise-induced collapse (EIC),
neuronal ceroid lipofuscinosis 4A (NCL), centronuclear myopathy
(HMLR), mucopolysaccharidosis VII (MPS VII), myotonia
congenita (MG), gangliosidosis (GM1) and muscular dystrophy
(Duchenne type) (GRMD)). The tests were performed in a dog
population from Belgium, the Netherlands and Germany. Eight
out of these 9 disorders are animal models for similar conditions in
humans. The mutations predicted to cause HD, DM, EIC and
NCL, were detected in a wide variety of breeds.
Materials and Methods
Ethics Statement
Approval from the local ethical (Faculty of Veterinary Medicine,
Ghent University, Belgium) and deontological (Federal Public
Service Health, Food Chain Safety and Environment, Brussels,
Belgium) committees was granted (EC2010_171 and
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EC2011_193). All efforts were made to minimize suffering.
Informed consent was obtained from owners of dogs before
enrollment in the study.
Sample Collection
Blood samples (K3EDTA) were collected for a genetic database
to study HD. Veterinarians from Belgium, the Netherlands and
Germany were asked to take a blood sample from every dog that
had a hip radiograph taken. Reasons for performing the procedure
varied from screening purposes (breeding and assistance dogs) to
dogs with clinical complaints (with HD in the differential
diagnosis). No prerequisites were made regarding breed, sex and
age.
Irrespective of breed, samples (n = 476) were tested for the
presence of mutations associated with 9 disorders (HD, DM, EIC,
NCL, HMLR, MPS VII, MG, GM1 and GRMD). Breeds where
the mutant allele has already been reported, can be found in
Table 1. A summary of breeds and samples per breed can be
found in Table 2. Additionally, a mixed breed group of 28 dogs
was tested.
Genotyping
Genomic DNA was isolated using routine procedures. For blood
samples, 10 ml of blood was washed 3 times with 150 ml of a Tris-
HCL based buffer. The procedure was performed with the use of
robotic equipment. The cell pellet was lysed with Proteinase K (0.5
units for 45 minutes at 56uC followed by heat inactivation at 95uC
for 5 minutes).
Genotyping was conducted using KASP (http://www.
kbioscience.co.uk), a competitive allele specific polymerase chain
reaction system, according to the manufacturer’s instructions.
Primer sequences were based on literature [7–16] and transformed
to be compatible with KASP. All tests are routinely run at the dr.
Van Haeringen Laboratorium (Wageningen, the Netherlands).
Statistical Analysis
Breed specific prevalence was analyzed in 8 breeds for which at
least 12 samples were available (German Shepherd Dog, Labrador
Retriever, Golden Retriever, Border Collie, Bernese Mountain
Dog, American Staffordshire Terrier, Boxer, Spanish Water Dog).
Hardy – Weinberg equilibrium (HWE) was tested with an online
calculator (www.tufts.edu/,mcourt01/Documents). Data are
available on request.
Results
No variation was found in any of the breeds for the mutations
putatively responsible for 5 of the 9 disorders (HMLR, MPS VII,
MG, GM1, GRMD). The mutations predicted to cause HD, DM,
EIC and NCL, were observed in a wide variety of breeds (49, 15, 3
and 2 breeds, respectively). Breeds where mutant alleles were
found are listed in Tables 3, 4, 5 and 6 for HD, DM, EIC and
NCL, respectively. For HD, DM, EIC and NCL mutant alleles
were newly discovered in 43, 13, 2 and 1 breed(s), respectively.
The mutant alleles for HD and EIC were also identified in mixed
breed dogs. For 25 of the 28 crossbreds, the parental breeds were
known and we have shown these breeds to possess the respective
mutant allele.
For 8 breeds, breed specific prevalence of alleles were reported
(Table 3–6). Comparisons with previous reports could only be
made for EIC in the Labrador Retriever: our population
contained a very high number of genetically affected dogs
(Table 7) [6]. HWE could be tested for HD in the German
Shepherd Dog and the Golden Retriever (no significant deviation).
For the Labrador Retriever, genotype frequencies for HD and
EIC both deviated significantly from HWE (p#0.001). The other
breeds and disorders were not tested due to low number of samples
and/or absence of variation.
Discussion
Since its first report in 1935, intensive research has focused on
hip dysplasia (HD), one of the most frequent orthopedic disorder
in dogs [17]. HD can be found in a wide variety of breeds [18,19].
Recently, a haplotype in the Fibrillin 2 (FBN2) gene has been
reported to be associated with this highly prevalent, multifactorial
disorder [9]. Fibrillins are components of extracellular microfibrils
and have both a structural and a regulatory function [20]. The
mutant AGC haplotype was identified in 49 different breeds in the
population under study (Table 3). In 44 breeds, this mutant allele
was reported for the first time. We identified the AGC haplotype as
the only allele in 10 breeds (Cavalier King Charles Spaniel (n = 4),
English Setter (n = 2), English Springer Spaniel (n = 1), Gordon
Setter (n = 1), Laekenois (n = 1), Mastino Napoletano (n= 1),
Rhodesian Ridgeback (n = 1), Saarlooswolfhond (n = 2), Siberian
Husky (n= 2), Standard Poodle (n = 2)), however few conclusions
can be made as the sample count is low (n= 17 overall). One
additional dog was homozygous for the mutant allele, but as the
breed was not correctly specified (Springer Spaniel without
mentioning English or Welsh Springer Spaniel), this sample was
excluded.
Degenerative myelopathy (DM) is characterized by progressive
ataxia and upper motor neuron spastic paresis. The majority of
dogs with DM start to develop symptoms from 5 years of age [21].
Diagnosis is not straightforward when patients are alive. Based on
clinical symptoms and exclusion of other disorders (for example
intervertebral disc disease, spinal cord neoplasia), DM can be the
most likely etiology, but formal diagnosis can only be achieved
post-mortem on histopathology [21]. Only for a subset of those
breeds in which DM has been reported clinically, this disorder has
been confirmed on histopathology. In 2009, a causal mutation was
discovered in the superoxide dismutase 1 (SOD1) gene for 5 breeds
(Table 1) with an age-dependent incomplete penetrance [8]. This
gene encodes a free radical scavenger [21]. We identified the
causal mutation in 15 breeds. In 2 breeds (Standard Poodle and
Bernese Mountain Dog) the disorder was confirmed both clinically
and on histopathology while in another 2 breeds (Border Collie
and Collie Rough) the diagnosis of DM was made only on clinical
examination [21]. We report the presence of the mutant allele in
these 4 breeds and in an additional 9 breeds, in which the disorder
has not yet been reported. We also confirmed the presence of the
mutant allele in the German Shepherd Dog and Boxer (Table 4).
DM has been clinically reported in the Labrador Retriever and
confirmed by histopathology in the Golden Retriever, but the
mutation has not yet been reported in these breeds [21]. In our
population of respectively 74 and 62 individuals, we also did not
identify the SOD1 mutation. The mutant allele might be
infrequently present in the population or a different mutation
might be responsible for the same disorder, as recently reported
[22].
Dogs with exercise-induced collapse (EIC) develop incoordina-
tion of the hind limbs, paraparesis and/or tetraparesis and have an
increased body temperature after strenuous exercise. A mutation
in the dynamin 1 (DNM1) gene was found to be responsible for this
disorder and an incomplete penetrance (influenced by the level of
physical activity) was suggested [11]. DNM1 is important in
neuronal synaptic vesicle recycling, especially during high levels of
activity [23]. This disorder is reported mainly in Labrador
Prevalence of Nine Genetic Disorders in the Dog
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Retrievers, but presence of the mutant allele has also been
reported in other retriever breeds [6,11]. We report on the
presence of the mutant allele for the first time in one English
Cocker Spaniel and one Hungarian Vizsla (Table 5). The
prevalence of EIC in our Labrador population was higher than
in a previous report (Table 7) [6]. The sample source seems to
affect the percentage of affected dogs: when samples were collected
from Labrador Retrievers in dog shows, field trials and from local
pet owners in Canada and the United States, the prevalence of
affected dogs was relatively low and in agreement with HWE
expectations [6]. The opposite was true for dogs that were
specifically tested for EIC and those results were in agreement with
the results from our study, although we did not specifically select
for those dogs. In our population of Labrador Retrievers, genotype
frequencies for both HD and EIC deviate significantly from HWE.
This might be a reflection of non-random sampling or selection
[4]. For HD, non-random sampling can be expected since our
dogs were initially collected to study this disorder. For EIC, the
reason for rejection of the HWE is not clear. For both HD and
EIC, our results tend to overestimate the number of affected dogs
based on HWE. A similar result was found in the pet population in
a previous study (26.9 versus 29.2%) [6].
Neuronal ceroid lipofuscinosis 4A (NCL) has been reported in
American Staffordshire Terriers with progressive ataxia [24]. The
causal mutation was discovered in 2010 in the Arylsulfatase G
(ARSG) gene and an incomplete penetrance was suggested [7].
Table 2. Breed and samples per breed tested.
Breed n % Breed n %
Airedale Terrier 2 0.4 Gordon Setter 1 0.2
Akita 1 0.2 Great Dane 1 0.2
American Bulldog 1 0.2 Hovawart 1 0.2
American Cocker Spaniel 1 0.2 Hungarian Vizsla 7 1.5
American Staffordshire Terrier 18 3.8 Jack Russell Terrier 2 0.4
Anatolian Shepherd Dog 2 0.4 Labrador Retriever 75 15.8
Appenzeller Sennenhund 1 0.2 Laekenois 1 0.2
Australian Kelpie 1 0.2 Large Munsterlander 1 0.2
Australian Shepherd 6 1.3 Leonberger 4 0.8
Basset Hound 1 0.2 Malinois 7 1.5
Berger de Picardie 2 0.4 Maltese 1 0.2
Bernese Mountain Dog 20 4.2 Mastino Napoletano 1 0.2
Blue Picardy Spaniel 1 0.2 Miniature Pinscher 1 0.2
Boerboel 1 0.2 Munsterlander 1 0.2
Border Collie 29 6.1 Nederlandse Schapendoes 1 0.2
Bouvier des Flandres 3 0.6 Newfoundland 4 0.8
Boxer 15 3.2 Nova Scotia Duck Tolling Retriever 3 0.6
Briard 1 0.2 Rhodesian Ridgeback 1 0.2
Bull Terrier 1 0.2 Rottweiler 7 1.5
Cavalier King Charles Spaniel 4 0.8 Saarlooswolfhond 2 0.4
Collie Rough 2 0.4 Saint Bernard Dog 3 0.6
Dalmatian 2 0.4 Samoyed 1 0.2
Dobermann 2 0.4 Shar Pei 4 0.8
Dogo Argentino 1 0.2 Shetland Sheepdog 1 0.2
Dogue de Bordeaux 5 1.1 Shiba 3 0.6
Dwergschnauzer 1 0.2 Siberian Husky 2 0.4
English Bulldog 4 0.8 Spanish Water Dog 12 2.5
English Cocker Spaniel 2 0.4 Springer Spaniela 1 0.2
English Setter 2 0.4 Stabyhoun 3 0.6
English Springer Spaniel 1 0.2 Standard Poodle 2 0.4
Epagneul Breton 2 0.4 Tervueren 2 0.4
Flat Coated Retriever 8 1.7 Tibetan Mastiff 1 0.2
French Bulldog 3 0.6 Weimaraner 4 0.8
German Shepherd Dog 73 15.3 White Swiss Shepherd Dog 5 1.1
Golden Retriever 62 13.0 Wire-Haired Pointing Griffon Korthals 1 0.2
Total 476
a = not specified whether English or Welsh Springer Spaniel.
doi:10.1371/journal.pone.0074811.t002
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ARSG encodes for a lysosomal enzyme [25]. The mutant allele has
a prevalence of approximately 9% in our 17 American Stafford-
shire Terriers which is less than the frequency expected based on a
previous study [24]. We report the presence of the same mutation
in the Bull Terrier, a breed where NCL has not been reported
(Table 6). No dogs were homozygous for the mutant allele in the
population studied.
For the other 5 disorders (HMLR, MPS VII, MG, GM1,
GRMD) the mutant alleles were not detected in our population.
Non-detection of the mutant allele might indicate that the allele is
absent, that it is present but at a low frequency and that the
number of samples tested was too low. For HMLR (Labrador
Retriever, n = 66) and MPS VII (German Shepherd Dog, n = 67),
we had, with the numbers of animals tested, a 99% chance of
detecting every allele with a minor allele frequency (MAF) of at
least 3.5% [26]. For GRMD (Golden Retriever, n = 19), we had a
99% chance of detecting alleles with a frequency of at least 11.5%
[26]. For MG, GM1 and MPS VII (in the Brazilian Terrier), the
sample size was too small to make any conclusions regarding the
absence of the mutant allele [26]. The allele frequency for HMLR
has previously been investigated [4]. In that study, the mutant
allele frequency was very low (1.8% or 0.47%). To be able to
detect all alleles with a MAF of 1% with a 99.9% probability, 344
samples would be needed. Since our sample count was much
lower, it cannot be concluded that any of these 5 mutant alleles are
completely absent.
For DM, EIC and NCL breeding advice can be given based on
our population study. For some disorders, the mutant allele
Table 3. Breeds where mutant alleles for hip dysplasia were found and breed specific prevalence for breeds with at least 12
samples.
NN NA AA Total HWE q (%)
n (%) n (%) n (%) n (%) P-value
American Staffordshire Terrier 4 (24) 9 (53) 4 (24) 17 (100) – 50
Bernese Mountain Dog 7 (35) 12 (60) 1 (5) 20 (100) – 35
Border Collie 25 (89) 3 (11) 0 (0) 28 (100) – 5
Boxer 15 (100) 0 (0) 0 (0) 15 (100) – 0
German Shepherd Dog 34 (47) 34 (47) 4 (6) 72 (100) 0.225 29
Golden Retriever 10 (16) 31 (51) 20 (33) 61 (100) 0.728 58
Labrador Retriever 32 (45) 21 (30) 18 (25) 71 (100) 0.001 40
Spanish Water Dog 4 (33) 8 (67) 0 (0) 12 (100) – 33
Others: Airedale Terrier, Appenzeller Sennenhund, Australian Shepherd, Blue Picardy Spaniel, Boerboel, Bouvier des Flanders,
Briard, Bull Terrier, Cavalier King Charles Spaniel, Collie Rough, Dalmatian, Dobermann, Dogo Argentino, Dogue de
Bordeaux, English Bulldog, English Cocker Spaniel, English Setter, English Springer Spaniel, Epagneul Breton, Flat Coated
Retriever, Gordon Setter, Hovawart, Hungarian Vizsla, Laekenois, Large Munsterlander, Leonberger, Malinois, Maltese,
Mastino Napoletano, Miniature Pinscher, Newfoundland, Nova Scotia Duck Tolling Retriever, Rhodesian Ridgeback,
Rottweiler, Saarlooswolfhond, Saint Bernard Dog, Shetland Sheepdog, Siberian Husky, Springer Spaniela, Stabyhoun,
Standard Poodle, Weimaraner, White Swiss Shepherd Dog
NN= 2 normal alleles, NA=heterozygous, AA= 2 mutant alleles, HWE=Hardy-Weinberg equilibrium, q =mutant allele frequency, % =percent of dogs belonging to
specific category, – = not applicable, a = not specified whether English or Welsh Springer Spaniel.
doi:10.1371/journal.pone.0074811.t003
Table 4. Breeds where mutant alleles for degenerative myelopathy were found and breed specific prevalence for breeds with at
least 12 samples.
NN NA AA Total HWE q (%)
n (%) n (%) n (%) n (%) P-value
American Staffordshire Terrier 18 (100) 0 (0) 0 (0) 18 (100) – 0
Bernese Mountain Dog 12 (60) 7 (35) 1 (5) 20 (100) – 23
Border Collie 27 (96) 1 (4) 0 (0) 28 (100) – 2
Boxer 13 (87) 2 (13) 0 (0) 15 (100) – 7
German Shepherd Dog 53 (73) 18 (25) 2 (3) 73 (100) – 15
Golden Retriever 62 (100) 0 (0) 0 (0) 62 (100) – 0
Labrador Retriever 74 (100) 0 (0) 0 (0) 74 (100) – 0
Spanish Water Dog 12 (100) 0 (0) 0 (0) 12 (100) – 0
Others: Airedale Terrier, Australian Shepherd, Cavalier King Charles Spaniel, Collie Rough, Dobermann, Dogo Argentino,
Saarlooswolfhond, Shetland Sheepdog, Stabyhoun, Standard Poodle, White Swiss Shepherd Dog
NN= 2 normal alleles, NA=heterozygous, AA= 2 mutant alleles, HWE=Hardy-Weinberg equilibrium, q =mutant allele frequency, % =percent of dogs belonging to
specific category, – = not applicable.
doi:10.1371/journal.pone.0074811.t004
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frequency is quite high in certain breeds (.40% in Labrador
Retriever for EIC). However, because of their recessive nature, a
relatively fast reduction of both the mutant allele frequency and
affected dogs can be achieved based on genetic tests. We propose
to exclude certain genotypic combinations of dogs from mating,
rather than excluding individuals, especially if high mutant allele
frequencies are found. For autosomal recessive diseases, dogs
homozygous for the mutant allele should not be combined with
each other or with heterozygous dogs. However, they can still be
used for breeding, but require a mating combination involving
only homozygous wild type animals to reduce the number of
affected dogs. As heterozygous dogs can be used the same way, no
dogs need to be excluded. As essentially every dog can still be used
for breeding, the clinical outcome of disorder can be prevented
without excessive exclusion of carrier or genetically affected dogs
from the breeding population. Reduction of the prevalence of HD
based only on FBN2 will be more difficult since it is a multifactorial
polygenetic disorder.
Surprisingly, mutant alleles for 3 autosomal recessive disorders
(DM, EIC and NCL) were found in 9, 2 and 1 breed(s) respectively
where the disorder has not been clinically reported. The most
plausible explanation might be that the disorder just has not been
recognized in those breeds. A second explanation is the influence
of the breed specific genetic background: the effect of mutations
might be different in different breeds. This has been reported in
Drosophila and the mouse [27,28]. In a meta-analysis in humans
where studies on a wide variety of diseases and genes were
compared, opposite effects between races were found, but none of
them significant [29]. To the authors’ knowledge, this phenom-
enon has not yet been reported in dogs.
This study reports on the presence of mutant alleles for 9
disorders in a wide variety of dog breeds. Veterinarians and dog
breeders should be aware that mutations are present in breeds
even where the disorder has not been reported. Dogs from non-
suspected breeds that show comparable symptoms to the disorders
reported in this and other studies should be genotyped and results
should be reported in order to create a reliable database. Ideally,
phenotypical information for every disorder should be included in
this database. As this is not available for all diseases in our
database, this is a major limitation to this study.
Table 5. Breeds where mutant alleles for exercise-induced collapse were found and breed specific prevalence for breeds with at
least 12 samples.
NN NA AA Total HWE q (%)
n (%) n (%) n (%) n (%) P-value
American Staffordshire Terrier 18 (100) 0 (0) 0 (0) 18 (100) – 0
Bernese Mountain Dog 18 (100) 0 (0) 0 (0) 18 (100) – 0
Border Collie 25 (100) 0 (0) 0 (0) 25 (100) – 0
Boxer 12 (100) 0 (0) 0 (0) 12 (100) – 0
German Shepherd Dog 69 (100) 0 (0) 0 (0) 69 (100) – 0
Golden Retriever 51 (100) 0 (0) 0 (0) 51 (100) – 0
Labrador Retriever 30 (46) 16 (25) 19 (29) 65 (100) ,0.001 42
Spanish Water Dog 12 (100) 0 (0) 0 (0) 12 (100) – 0
Others: Hungarian Vizsla, English Cocker Spaniel
NN= 2 normal alleles, NA=heterozygous, AA= 2 mutant alleles, HWE=Hardy-Weinberg equilibrium, q =mutant allele frequency, % =percent of dogs belonging to
specific category, – = not applicable.
doi:10.1371/journal.pone.0074811.t005
Table 6. Breeds where mutant alleles for neuronal ceroid lipofuscinosis 4A were found and breed specific prevalence for breeds
with at least 12 samples.
NN NA AA Total HWE q (%)
n (%) n (%) n (%) n (%) P-value
American Staffordshire Terrier 14 (82) 3 (18) 0 (0) 17 (100) – 9
Bernese Mountain Dog 19 (100) 0 (0) 0 (0) 19 (100) – 0
Border Collie 26 (100) 0 (0) 0 (0) 26 (100) – 0
Boxer 13 (100) 0 (0) 0 (0) 13 (100) – 0
German Shepherd Dog 71 (100) 0 (0) 0 (0) 71 (100) – 0
Golden Retriever 57 (100) 0 (0) 0 (0) 57 (100) – 0
Labrador Retriever 70 (100) 0 (0) 0 (0) 70 (100) – 0
Spanish Water Dog 12 (100) 0 (0) 0 (0) 12 (100) – 0
Others: Bull Terrier
NN= 2 normal alleles, NA=heterozygous, AA= 2 mutant alleles, HWE=Hardy-Weinberg equilibrium, q =mutant allele frequency, % =percent of dogs belonging to
specific category, - = not applicable.
doi:10.1371/journal.pone.0074811.t006
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